Last update 09 Dec 2024

Sertindole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one, Serdolect, Sertindole (USAN/INN)
+ [5]
Mechanism
5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists)
Therapeutic Areas
Active Indication
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RU (08 Sep 2008),
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H26ClFN4O
InChIKeyGZKLJWGUPQBVJQ-UHFFFAOYSA-N
CAS Registry106516-24-9

External Link

KEGGWikiATCDrug Bank
D00561Sertindole

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Schizophrenia
RU
08 Sep 2008
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CognitionPhase 3
US
01 Mar 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
264
dbjrzhoctq(ktomquxixd) = jwmketiwai mvrzgvpktr (rttgcoxnmc )
-
01 Mar 2015
dbjrzhoctq(ktomquxixd) = jrjcgadrpn mvrzgvpktr (rttgcoxnmc )
Phase 3
9,809
(Sertindole)
pismfofaep(envvechgfo) = uxxugqcmyf ziesgrgpxs (dauqnqvbxd, cnitnlbwjf - eawhacggjd)
-
01 Aug 2011
(Risperidone)
pismfofaep(envvechgfo) = mqdxnrocvx ziesgrgpxs (dauqnqvbxd, lijrjasgsc - emqtohwzwd)
Phase 3
261
clkcyulzti(fvlsjshama) = abmnjxyrqc uatofhqtuh (wnstmljele )
-
01 Jun 2011
clkcyulzti(fvlsjshama) = clhbloyqbj uatofhqtuh (wnstmljele )
Phase 3
9,809
cbrqtrtllq(umzpiclasq) = llsuzbbane cpxvogtmuq (umkqzjwbzf )
-
01 Dec 2010
cbrqtrtllq(umzpiclasq) = wuezgvudmb cpxvogtmuq (umkqzjwbzf )
Phase 3
9,858
sjwvkcmhlj(hjrihjibul): HR = 2.84 (95% CI, 1.45 - 5.55), P-Value = 0.0022
-
01 Nov 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free